Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base

GISSI Coordinating Center, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

OBJECTIVES. This study was designed to reassess the prediction of recurrent nonfatal myocardial infarction in patients recovering from acute myocardial infarction after thrombolysis. BACKGROUND. Recurrent nonfatal myocardial infarction is a strong and independent predictor of subsequent mortality. Current knowledge of risk factors for nonfatal reinfarction is still largely based on data gathered before the advent of thrombolysis. Thus, this prospective study was planned to identify harbinger of nonfatal reinfarction in the postinfarction patients of the multicenter Grouppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) trial. METHODS. Predictors of nonfatal reinfarction at 6 months were analyzed by multivariate technique (Cox model) in 8,907 GISSI-2 survivors of myocardial infarction with clinical follow-up, relying on a set of prespecified variables reflecting residual ischemia, left ventricular failure or dysfunction, complex ventricular arrhythmias, comorbidity as well as demographic and historical factors. RESULTS. The postdischarge to 6-month incidence rate of nonfatal reinfarction was 2.5%. Independent predictors of nonfatal reinfarction were cardiac ineligibility for exercise test (relative risk 2.97, 95% confidence interval [CI] 1.98 to 4.45), previous myocardial infarction (relative risk 1.70, 95% CI 1.22 to 2.36) and angina at follow-up (relative risk 1.50, 95% CI 1.10 to 2.04). On further multivariate analysis, performed in 6,580 patients with both echocardiographic and electrocardiographic monitoring data available, a history of angina emerged as an additional risk predictor (relative risk 1.58, 95% CI 1.10 to 2.25). CONCLUSIONS. The 6-month incidence of nonfatal reinfarction is rather low in survivors of myocardial infarction after thrombolysis. Cardiac ineligibility for exercise testing and a history of coronary artery disease are risk predictors. Recurrent nonfatal infarction is not predictable by qualitative variables reflecting residual ischemia, except by postdischarge angina. Prediction of nonfatal reinfarction appears less accurate than prediction of mortality, as almost 50% of reinfarctions occur in patients without any of the identified risk factors.

This article has been cited by other articles:

				J. J. Thune, J. E. Signorovitch, L. Kober, J. J. V. McMurray, K. Swedberg, J. Rouleau, A. Maggioni, E. Velazquez, R. Califf, M. A. Pfeffer, et al. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction Eur J Heart Fail, February 1, 2011; 13(2): 148 - 153. [Abstract] [Full Text] [PDF]

				B. Amasyali, K. Aytemir, S. Kose, A. Kilic, G. Abali, A. Iyisoy, H. Kursaklioglu, M. Turan, N. Bingol, E. Isik, et al. Admission Plasma Leptin Level Strongly Correlates With the Success of Thrombolytic Therapy in Patients With Acute Myocardial Infarction Angiology, January 1, 2007; 57(6): 671 - 680. [Abstract] [PDF]

				J E Udelson and E J Flint Radionuclide imaging in risk assessment after acute coronary syndromes Heart, August 1, 2004; 90(suppl_5): v16 - v25. [Full Text] [PDF]

				S. J. Kernis, K. J. Harjai, G. W. Stone, L. L. Grines, J. A. Boura, M. W. Yerkey, W. O'Neill, and C. L. Grines The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1173 - 1177. [Abstract] [Full Text] [PDF]

				D. Scrutinio, C. Cimminiello, E. Marubini, M. Vittoria Pitzalis, M. Di Biase, P. Rizzon, and the STAMI Group Ticlopidine versus aspirin after myocardial infarction (stami) trial J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1259 - 1265. [Abstract] [Full Text] [PDF]

				L. Tavazzi and A. Volpi Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials Circulation, March 4, 1997; 95(5): 1341 - 1345. [Full Text]

				L. Tavazzi Overview European Journal of Cardiovascular Prevention & Rehabilitation, December 1, 1994; 1(4): 287 - 289. [PDF]

				A. Volpi and A. Cavalli High- and Low-Risk Groups: Early and Late Prognostic Stratification European Journal of Cardiovascular Prevention & Rehabilitation, December 1, 1994; 1(4): 295 - 300. [Abstract] [PDF]

				A. Giordano, M. Galli, and C. Marcassa Evidence of Residual Ischaemia: Real Danger or Myth? European Journal of Cardiovascular Prevention & Rehabilitation, December 1, 1994; 1(4): 314 - 321. [Abstract] [PDF]